Signoria's export and capex guidance contradicted itself within the same call
Management set a 25% export target for FY27, then said they cannot give any numbers because exports haven't started. The capex story wobbled too.
What's new
- FY27 revenue target is ₹80 cr (Signoria ₹50 cr, Herbal Print ₹30 cr) with a minimum 12% PAT margin.
- FY28 target is ₹120 cr, requiring ₹50 lakh capex for 200 additional machines at year-end.
- April-May sales hit ₹4.5 cr and ₹4.18 cr, up from ₹2-3 cr prior year, validating inventory buildup.
- Inventory doubled to ₹23-23.5 cr from ₹12-12.5 cr to support volume growth.
Themes from the call
Guidance
Management gave a specific 25% export target and a firm capex timeline, then walked both back within the same call.
Demand
Early FY27 sales momentum is strong, with April-May revenue nearly doubling year-on-year on the back of inventory stocking.
Margins
FY26 margins compressed on raw material and GST costs; management is confident of a 12% PAT margin in FY27 after May price hikes.
Guidance watch
- Management set a 25% FY27 export target but then said it cannot provide exact export numbers as exports haven't started.
- The ₹80 cr FY27 target is described as achievable with current machines; 200 new machines are for FY28's ₹120 cr target.
Risk flags
- Contradictory statements on both export targets and capex timing within a single call create ambiguity on near-term execution.
- Inventory has doubled to ₹23.5 cr, tying up capital; success depends on sustained demand at ₹4-4.5 cr monthly levels.
- Exports are currently negligible (under 5%), making the 25% target an aspiration with no operational foundation yet.
Key quotes
-
"We have decided on 25% for exports, but currently we are not exporting because we are unable to fulfill the entire supply in the domestic market itself."
— Signoria management, Jun 2026 call -
"Regarding exports, I cannot say anything exact right now because we haven't done exports yet - no exports at all."
— Signoria management, Jun 2026 call
The brief
Signoria Creation's earnings call featured guidance that contradicted itself in real time. Management first put a number on exports — 25% of revenue in FY27 — then, minutes later, said it couldn't give any export projections because the company hasn't started exporting. The same pattern appeared on capex: one statement said 200 new machines must be installed this year to meet demand, while another said the current setup can comfortably hit the ₹80 cr target and new machines are only needed for year-end to support FY28's ₹120 cr goal.
The underlying business is moving. April-May sales hit ₹4.5 cr and ₹4.18 cr, nearly double the ₹2-3 cr prior-year run rate, after management deliberately doubled inventory to ₹23.5 cr. That stocking strategy is producing results in the first two months of the fiscal year. Management has also shown pricing power, with May rate increases accepted by customers despite raw material inflation.
The core question is whether management can commit to a single plan. If exports are under 5% today, a 25% target is an aspiration, not a plan. If the existing 200 machines can hit ₹80 cr, the urgent need for 200 more this year is less clear. The Herbal Print acquisition adds a printing subsidiary with its own ₹30 cr target, but the integration story is early.
Management's tone oscillated between ambition and caution. CEO Vasudev Agarwal compared his vision to an AGL Tiles distributorship that hit ₹1,800 cr, but the company's own targets are ₹80 cr this year. The 12% PAT margin floor is credible after the May price hikes, but depends on sustained volume at ₹4-4.5 cr per month for 12 months. The contradictions on guidance make the path harder to underwrite.
Signoria has real sales momentum but gave two different versions of its own plan in a single call.